Evidence map›Paper›PMID 42073564›Full record

ArticleCancers2026

Real-World Data on the Effectiveness of Immunotherapy on Advanced NSCLC: A Retrospective Cohort Study.

Antonios Katsarolis, Iliana Tapazidou-Spanoudi, Dimitris Kugiumtzis, Nikoleta Pastelli, Dionisios Spyratos, Katerina Manika, Anastasios Vagionas, Sofia Lampaki, Elena Fountzilas

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Antonios KatsarolisSchool of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.ORCID 0009-0006-3317-4009
Iliana Tapazidou-SpanoudiDepartment of Biology, University of Rome Tor Vergata, 00133 Rome, Italy.
Dimitris KugiumtzisSchool of Electrical and Computer Engineering, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.ORCID 0000-0002-5337-5688
Nikoleta PastelliDepartment of Pathology, "George Papanikolaou" General Hospital, 57010 Thessaloniki, Greece.
Dionisios SpyratosOncology Unit, Pulmonology Clinic, "George Papanikolaou" General Hospital, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Katerina ManikaOncology Unit, Pulmonology Clinic, "George Papanikolaou" General Hospital, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Anastasios VagionasOncology Department, General Hospital of Kavala, 65500 Kavala, Greece.
Sofia LampakiOncology Unit, Pulmonology Clinic, "George Papanikolaou" General Hospital, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Elena FountzilasOncology Unit, Pulmonology Clinic, "George Papanikolaou" General Hospital, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.

Funding

HeSMO NA
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

effectivenessimmunotherapynon-small-cell lung cancerreal-world datasurvival

Identifiers

PMID42073564
PMCPMC13115517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.